MicroRNA-9-5p functions as a tumor suppressor in prostate cancer via targeting UTRN
dc.contributor.author | Guo, Zhenyu | |
dc.contributor.author | Huang, Shuchang | |
dc.contributor.author | Zhou, Yihong | |
dc.contributor.author | Cheng, Wenjie | |
dc.contributor.author | Chu, Xi | |
dc.contributor.author | Zheng, Xiaoqing | |
dc.contributor.author | Zheng, Hao | |
dc.date.accessioned | 2020-05-19T07:54:47Z | |
dc.date.available | 2020-05-19T07:54:47Z | |
dc.date.issued | 2019-11-07 | |
dc.description.abstract | Accumulating evidence indicates that miR-9-5p plays an important role in several diseases, especially tumor progression. In this study, we investigated the clinical significance and biological function of miR-9-5p in prostate cancer (PCa). Using quantitative real time PCR (qRT-PCR) analysis, we found miR-9-5p level was significantly down-regulated in PCa tissues and cell lines. The decreased miR-9-5p expression was associated with tumor size, preoperative PSA, Gleason score and lymph node metastasis. Kaplan-Meier survival analysis showed patients with low level of miR-9-5p had significantly decreased rates of overall survival (OS). Multivariate analyses showed that miR-9-5p was an independent predictor of PCa patients’ prognosis. Through CCK-8 and Transwell assays, miR-9-5p overexpression by miR-9-5p mimics transfection was demonstrated to suppress the proliferation, migration and invasion of PCa cells. Mechanistically, luciferase reporter assay, qRT-PCR and Western blot demonstrated that Utrophin (UTRN) is a direct target of miR-9-5p in PCa cells. The status of UTRN protein in PCa tissues was much higher than that in adjacent tissues by immunohistochemical staining and its mRNA levels were inversely correlated with miR-9-5p in PCa tissues. Importantly, UTRN knockdown by siUTRN imitated the suppressive effects of miR-9-5p on cell proliferation, migration and invasion in PCa. In summary, miR-9-5p might novel prognostic biomarker in and targeting UTRN by miR-9-5p could be potential therapeutic candidates for PCa. | en |
dc.identifier.issn | 1611-2156 | |
dc.identifier.uri | http://hdl.handle.net/2003/39113 | |
dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-21031 | |
dc.language.iso | en | |
dc.relation.ispartofseries | EXCLI Journal;Vol. 18 2019 | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Prostate cancer | en |
dc.subject | miR-9-5P | en |
dc.subject | UTRN | en |
dc.subject | Prognosis | en |
dc.subject | Cell proliferation | en |
dc.subject | Migration | en |
dc.subject.ddc | 610 | |
dc.title | MicroRNA-9-5p functions as a tumor suppressor in prostate cancer via targeting UTRN | en |
dc.type | Text | |
dc.type.publicationtype | article | |
dcterms.accessRights | open access | |
eldorado.dnb.zdberstkatid | 2132560-1 | |
eldorado.secondarypublication | true |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 4.85 KB
- Format:
- Item-specific license agreed upon to submission
- Description: